首页> 外文期刊>Expert Review of Molecular Diagnostics >Multiplex diagnostic platforms for detection of biothreat agents.
【24h】

Multiplex diagnostic platforms for detection of biothreat agents.

机译:用于检测生物威胁剂的多重诊断平台。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The availability of rapid, sensitive and cost-effective diagnostic methods is paramount to the success of a comprehensive national health security system in the USA. The national networks that were established to safeguard US infrastructures (e.g., public health, livestock, agriculture and water supply) have developed sufficient capability and capacity for monitoring. However, additional advanced methods will be required to maintain operational readiness. Currently available methods, although sensitive and specific, are generally costly and not amenable to high-throughput analyses. Critical to the success of biothreat surveillance is the ability to screen for and detect multiple agents rapidly in a single reaction and with minimal sample processing. This review will examine currently available diagnostic platforms (i.e., PCR-, immuno- and array-based) and biosensors that can detect multiple biothreat analytes in a single reaction (i.e., multiplex assays). The maturity, benefits and limitations of each platform will be described and a prospective view, from current to future state of the art, will be proposed.
机译:快速,灵敏和具有成本效益的诊断方法的可用性对美国全面的国家健康安全体系的成功至关重要。为维护美国基础设施(例如,公共卫生,牲畜,农业和水供应)而建立的国家网络已经建立了足够的监控能力。但是,将需要其他高级方法来保持操作就绪。当前可用的方法尽管敏感且特异,但通常成本高昂,并且不适合高通量分析。生物威胁监测成功的关键是能够在单个反应中以最少的样品处理快速筛选和检测多种药物的能力。这篇评论将检查当前可用的诊断平台(即基于PCR,基于免疫和基于阵列的诊断平台)和可在单个反应中检测多种生物威胁分析物的生物传感器(即多重测定)。将描述每个平台的成熟度,优势和局限性,并提出从当前到未来的最新观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号